Methylprednisolone Sodium Succinate — 500MG, Powder for solution for injection, 10 mL vial

Methylprednisolone Sodium Succinate — 500MG, Powder for solution for injection, 10 mL vial

Methylprednisolone Sodium Succinate is a powder for solution for injection for intramuscular; intravenous use. When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of Methylprednisolone Sodium Succinate for Injection, USP, is indicated as follows: Allergic states Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).

• Active ingredient or product type: METHYLPREDNISOLONE SODIUM SUCCINATE
• Strength/concentration: 500MG
• Dosage form and route: Powder for solution for injection, Intramuscular; Intravenous
• Exact package presentation: 10 mL vial
• NDC/item number: 0143-9850-01
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at controlled room temperature according to the current product labeling.
• Status: Rx only

Important safety information: Review the current product labeling for product-specific contraindications, warnings, and precautions before use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.